Market Driven Regulatory Strategy

Aligning MDR, IVDR, and FDA strategies with business objectives - creating coherent, cross-market pathways from classification to CE marking and FDA clearance. Through early Notified Body engagement, data-driven planning, and evidence alignment, we reduce approval time and strengthen global market readiness. Target: More predictable approvals, synchronized global strategies, and faster commercialization with reduced regulatory risk.